EXHIBIT 10.1
Liminatus Pharma, Inc.
REGISTRATION RIGHTS AGREEMENT
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is entered into as of June 29, 2026, by and among Liminatus Pharma, Inc., a Delaware corporation (the “Company”) and the undersigned parties listed under Stockholders on the signature page hereto (each, an “Stockholder” and collectively, the “Stockholders”).
WHEREAS, pursuant to a Merger Agreement, dated as of May 17, 2026 and amended and restated as of June 29, 2026 (as further amended and supplemented from time to time, the “Merger Agreement”), by and among the Company, InnocsAI LLC, Delaware limited liability company (“InnocsAI”), NamChul Jung, an individual, as the representative of the members of InnocsAI, the Stockholders agreed to accept the Merger Shares (i.e., Common Stock and Preferred Stock of the Company) in exchange for their membership interests of InnocsAI;
…